GRI Bio
7 hedge funds and large institutions have $14.7K invested in GRI Bio in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.13% less ownership
Funds ownership: 0.19% → 0.07% (-0.13%)
13% less funds holding
Funds holding: 8 → 7 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
95% less capital invested
Capital invested by funds: $277K → $14.7K (-$262K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
+$25K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$207K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.81K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$56 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $5.72K | +$16.6K | +386 | +87% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $4.2K | – | – | – |
|
|
SG
3
StoneX Group
New York
| $4.01K | +$25K | +580 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $704 | -$1.81K | -42 | -29% |
|
5
BlackRock
New York
| $52 | – | – | – |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $29 | – | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $5 | – | – | – |
|
|
DS
8
DRW Securities
Chicago,
Illinois
| – | -$207K | -3,593 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$56 | -1 | Closed |
|
GRI Hedge Fund Activity: Q4 2025 in Review
7 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in GRI Bio (GRI) for Q4 2025, worth a combined $14.7K — down 95% from $277K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GRI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was StoneX Group, opening a new position worth an estimated $25K. The largest seller was DRW Securities, exiting entirely with an estimated $207K sold.
- 7 institutional investors held GRI Bio (GRI) as of Q4 2025, down from 8 in Q3 2025.
- Funds reported $14.7K of GRI Bio stock for Q4 2025, down 95% quarter-over-quarter.
- 1 fund opened new GRI Bio positions in Q4 2025 and 2 closed out, a net change of -1 holder.
- The largest GRI Bio buyer in Q4 2025 was StoneX Group, an estimated $25K added.
- The largest GRI Bio seller in Q4 2025 was DRW Securities, an estimated $207K sold.
Based on aggregated 13F filings for Q4 2025.